Autopsy report · NCT03535493

The Effect of ACT and Float REST on Burnout Syndrome.

“Ethics Committee concerns.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 months before it stopped.
• 45 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Amrinder Babbra

Sponsor type

University, hospital or other

Conditions

Burnout Syndrome

Interventions

Acceptance and Commitment Therapy (ACT); Float REST; ACT + Float REST

Participants

45

Sites

1

Countries

United States

Trials that died the same way

• Identification of Post-Traumatic Stress Disorder in Adult Patients With Substance Use Disorders
  “Refusal by the Ethics Committee” (74% match in meaning)
• Depression and Major Adverse Events in Older Patients Who Undergo a Transcatheter Aortic Valve Implantation
  “Reclassification by Ethics Committee” (68% match in meaning)
• Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin
  “Not approved by the coordinating Ethical Committee” (67% match in meaning)
• Effect of Intra-articular Injection on Temporomandibular Joint Dysfunction
  “ethical issues” (66% match in meaning)
• Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
  “No approval from ethical committee” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.